| Application no. and date | 06838636.6 (espacenet) (Federated) (European Patent Register), 20061129 | | Patent/reg. no. and date | DK/EP 1954281, 20110309 | | Publication date | 20080813 | | Priority no. and date | US 740308 P, 20051129 | | EP pub. no. and date |
EP 1954281 20080813 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 154746 | | Inventor | PANDITE, Arundathy Nirmalini, GlaxoSmithKline
c/o Corporate Intellectual Property Department
Five Moore Drive
PO Box 13398
Research Triangle Park, NC 27709-3398, US,
WHITEHEAD, Bonnie F., GlaxoSmithKline
c/o Corporate Intellectual Property Department
Five Moore Drive
Po Box 13398
Research Triangle Park, NC 27709-3398, US,
HO, Peter T.C., GlaxoSmithKline
c/o Corporate Intellectual Property Department
1250 South Collegeville Road
Po Box 5089
Collegeville, PA 19426, US,
SUTTLE, Albert Benjamin, GlaxoSmithKline
c/o Corporate Intellectual Property Department
Five Moore Drive
PO Box 13398
Research Triangle Park, NC 27709-3398, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 35/00 (2006.01) | | Title | Fremgangsmåde til cancerbehandling | | Int. application no. | US2006045777 | | Int. publication no. | WO2007064753 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
